Test 5, 10-Methylenetetrahydrofolate Reductase Mutations, Genomic Dna Pcr
OMM is the FDA product code for Test 5, 10-Methylenetetrahydrofolate Reductase Mutations, Genomic Dna Pcr, a class II device type, regulated under 21 CFR 864.7280. FDA's definition for this code reads: "In vitro diagnostic for the detection and genotyping of a single point mutation of the human 5, 10-methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia". As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- OMM
- Device name
- Test 5, 10-Methylenetetrahydrofolate Reductase Mutations, Genomic Dna Pcr
- FDA definition
- In vitro diagnostic for the detection and genotyping of a single point mutation of the human 5, 10-methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia.
- Regulation
- 21 CFR 864.7280
- Device class
- Class II
- Review panel
- Hematology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 2
- Ingested recalls
- 0
Clearances, product code OMM
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2011 | 2 |
Applicants with the most clearances
Product code OMM| Applicant | Clearances |
|---|---|
| Hologic, Inc. | 2 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
